What is Poly-Med?
Poly-Med is a distinguished entity in the life sciences industry, specializing in the development and manufacturing of high-performance, absorbable biomaterials. The company excels in converting these advanced materials into precision components and sophisticated implantable medical devices. Its comprehensive product portfolio encompasses bioresorbable polymers, specialized extrusions, biomedical textiles, and innovative wound and burn tissue scaffolds. These offerings are strategically targeted at critical markets, including orthopedics and soft tissue reinforcement. Poly-Med provides end-to-end services, from initial design and development to vertically integrated manufacturing and rigorous analytical testing, empowering clients to bring novel medical device concepts to fruition. The company's unwavering commitment to quality and patient outcomes solidifies its leadership in the medical technology landscape.
How much funding has Poly-Med raised?
Poly-Med has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Poly-Med
PPP
Public-Private Partnership
What's next for Poly-Med?
The recent major strategic investment signals a pivotal phase for Poly-Med, likely enabling accelerated expansion of its manufacturing capabilities and further research into next-generation absorbable biomaterials. This capital infusion is expected to fuel the company's growth trajectory, potentially leading to broader market penetration and the development of new therapeutic applications. Strategic partnerships and continued innovation will be key as Poly-Med leverages this backing to enhance its competitive edge and solidify its role as a leader in implantable medical devices and advanced biomaterials.
See full Poly-Med company page
